Please check your internet connection and try again.
# Hepamerz (l-Ornithine l-Aspartate)
## Overview
Hepamerz is a combination of the amino acids l-ornithine and l-aspartate. It is thought to reduce ammonia levels by stimulating the urea cycle and promoting the detoxification of ammonia into glutamine.
## Primary Indications
* Treatment of latent and manifest hepatic encephalopathy.
* Adjunctive treatment in chronic liver diseases.
## Adult Dosing
* **Hepatic Encephalopathy:** Typically 3 g to 6 g orally three times daily, or 5 g to 10 g intravenously (IV) daily. The specific dose and frequency depend on the severity of hepatic encephalopathy and patient response. Maximum daily IV dose is generally 20 g.
## Pediatric Dosing
* There is **limited data** for pediatric use. Dosing in pediatric patients should be individualized and determined by a specialist.
## Dose Adjustments
* No specific dose adjustments are typically recommended for renal or hepatic impairment, as the drug is metabolized in the liver and excreted by the kidneys. However, caution is advised in patients with severe renal impairment.
## Contraindications
* Severe renal insufficiency (creatinine clearance < 25 mL/min).
* Hypersensitivity to l-ornithine, l-aspartate, or any component of the formulation.
## Adverse Effects
* **Gastrointestinal:** Nausea, vomiting, diarrhea, abdominal pain, flatulence.
* **Other:** Dizziness, headache, fatigue, skin rash.
* Rarely: Allergic reactions.
## Key Drug Interactions
* None well-established. However, concurrent use with other drugs affecting ammonia levels or the urea cycle should be monitored.
## Monitoring
* **Clinical:** Mental status, neurological function, signs and symptoms of hepatic encephalopathy.
* **Laboratory:** Ammonia levels (though correlation with clinical status can be variable), liver function tests, renal function.
## Clinical Pearls
* Hepamerz is often used as an adjunct therapy.
* Oral formulations are typically used for long-term management, while IV formulations may be used for more acute or severe presentations.
* The timing of administration relative to meals can influence absorption.
* Effectiveness may vary between individuals, and ammonia levels do not always directly correlate with clinical improvement.
---
*Disclaimer: This information is intended for clinical professionals. Always consult the official prescribing information and relevant guidelines for complete and up-to-date details before making any clinical decisions.*
